Cera Sanitaryware Limited announced the exercise of 170 stock options granted under its Employee Stock Option Scheme 2024 (ESOS 2024). These options were vested on June 5, 2025. Importantly, the exercise resulted in no change to the company’s paid-up equity share capital, as the requisite shares were sourced from the secondary market. The company provided full details of the scheme, including vesting schedules and pricing, as required.
Stock Option Exercise Notification
Cera Sanitaryware Limited has informed the exchanges regarding the exercise of stock options granted under the Cera Sanitaryware – Employee Stock Option Scheme 2024 (‘ESOS 2024’). Eligible employees exercised their rights for an aggregate of 170 Options which were originally granted on June 5, 2024.
The options exercised were those that vested on June 5, 2025. The CERA Sanitaryware Employees Welfare Trust is currently processing the transfer of these equity shares to the option grantees.
Impact on Share Capital
A crucial disclosure confirms that the exercise of these 170 options will have no impact on the paid-up equity share capital of the Company. This is because the necessary shares were sourced from the secondary market rather than being newly issued by the company.
ESOS 2024 Scheme Details Summary
The formal disclosure provided extensive details regarding the structure of the ESOS 2024 scheme:
- The total grant covered 14,950 Equity Shares with a face value of Rs. 5/- each.
- The exercise price for each option was set at the face value of the shares, amounting to Rs. 5/- per Option. The total money realized from the 170 options exercised was Rs. 850/-.
- Vesting began on the 1st anniversary from the grant date (June 5, 2025), where 10% (1,496 options) vested.
- The full vesting schedule is spread over five years: 10% on the 1st anniversary, 15% on the 2nd, 15% on the 3rd, 30% on the 4th, and 30% on the 5th anniversary.
- The time frame within which vested options can be exercised is a maximum of 5 (Five) years from the relevant vesting date.
The filing, dated February 17, 2026, confirms compliance with the necessary corporate disclosure procedures, with the complete scheme details provided in the attached Annexure.
Source: BSE
